Novo rations Ozempic starter kits amid surge in use for weight loss

[ad_1] A handout photo shows a nine-month supply of Novo Nordisk’s diabetes drug Ozempic which was purchased by an individual from online pharmacies in the UK for “off-label” use for…

With Novo Nordisk, Denmark Wants to Avoid the Nokia Trap

[ad_1] Welcome to the weekend issue of Brussels Edition, Bloomberg’s daily briefing on what matters most in the heart of the European Union. Join us on Saturdays for deeper dives…

Novo Nordisk’s Wegovy reduces heart-related risks

[ad_1] Novo Nordisk’s Wegovy trial results show cardiovascular benefits of the weight-loss drug. Michael Siluk/UCG/Universal Images Group via Getty Images The Danish pharma giant Novo Nordisk has found itself at…

Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events

[ad_1] Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael…

Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

[ad_1] Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6 billion to boost production capacity. Copyright ©2023 Dow Jones…

Drugmaker Novo Nordisk seeks obesity, diabetes ‘bolt-on’ deals

[ad_1] Flags with the Novo Nordisk logo flutter outside their Danish company’s offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little Acquire Licensing Rights Novo first to market with effective…

Novo Nordisk invests $6 bln in Wegovy production, still far below demand -CEO

[ad_1] The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing Rights LONDON/COPENHAGEN, Nov 10 (Reuters) – Obesity drug maker Novo Nordisk (NOVOb.CO)…

Novo Nordisk to invest $6 bln in Denmark expansions

[ad_1] Adds detail on investments in paragraphs 2-4, 6 OSLO, Nov 10 (Reuters) – Novo Nordisk NOVOb.CO said on Friday it will invest more than 42 billion Danish crowns ($6…

Novo Holdings A/S, a subsidiary of Novo Nordisk Foundation, becomes interested party in the Tel Aviv Stock Exchange (TASE), holding 8.42% shares

[ad_1] TEL AVIV, Israel, Nov. 7, 2023 /PRNewswire/ — The Tel Aviv Stock Exchange Ltd (TASE: TASE) is pleased to announce the receipt, on Nov 02, 2023, of a notification from…

Is it a Good Time to Dispose Your Novo Nordisk (NVO) Shares?

[ad_1] Polen Capital, an investment management firm, released its “Polen Global Growth” third quarter 2023 investor letter, a copy of which can be downloaded here. Polen Capital’s Global Growth Composite…